1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. KRONOS BIO INC
Kronos Bio Inc XNAS: KRON

Watchlist

Portfolio

Alert

Share


Insider Trading disclosures for Kronos Bio Inc

The latest disclosure was made by Arie S. Belldegrun in Kronos Bio Inc where a trade of 34,000 Stock Option (Right to Buy) done was reported to US exchanges on June 20, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Arie S. Belldegrun Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 34,000 0 - - Stock Option (Right to Buy)
Arie S. Belldegrun Director 20 Jun 2025 2,765,314 0 - 0.6 1,576,229 Common Stock
Arie S. Belldegrun Director 20 Jun 2025 679,575 0 - 0.6 387,358 Common Stock
Arie S. Belldegrun Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 20,600 0 - - Stock Option (Right to Buy)
Arie S. Belldegrun Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 34,000 0 - - Stock Option (Right to Buy)
Arie S. Belldegrun Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 34,000 0 - - Stock Option (Right to Buy)
Joshua A. Kazam Director 20 Jun 2025 94,481 0 - 0.6 53,854 Common Stock
Joshua A. Kazam Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 20,600 0 - - Stock Option (Right to Buy)
Joshua A. Kazam Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 34,000 0 - - Stock Option (Right to Buy)
Joshua A. Kazam Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 34,000 0 - - Stock Option (Right to Buy)
Joshua A. Kazam Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 34,000 0 - - Stock Option (Right to Buy)
Norbert W. Bischofberger Director, Ten Percent Owner 20 Jun 2025 263,750 0 - 0.6 150,338 Common Stock
Norbert W. Bischofberger Director, Ten Percent Owner 20 Jun 2025 263,750 0 - 0.6 150,338 Common Stock
Norbert W. Bischofberger Director, Ten Percent Owner Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 297,186 0 - - Employee Stock Option (Right to Buy)
Norbert W. Bischofberger Director, Ten Percent Owner Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 400,000 0 - - Employee Stock Option (Right to Buy)
Norbert W. Bischofberger Director, Ten Percent Owner Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 570,868 0 - - Employee Stock Option (Right to Buy)
Norbert W. Bischofberger Director, Ten Percent Owner Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 699,800 0 - - Employee Stock Option (Right to Buy)
Norbert W. Bischofberger Director, Ten Percent Owner 20 Jun 2025 10,802,138 0 - 0.6 6,157,219 Common Stock
Norbert W. Bischofberger Director, Ten Percent Owner 20 Jun 2025 263,750 0 - 0.6 150,338 Common Stock
Norbert W. Bischofberger Director, Ten Percent Owner 20 Jun 2025 263,750 0 - 0.6 150,338 Common Stock
Taiyin Yang Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 5,150 0 - - Stock Option (Right to Buy)
Taiyin Yang Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 41,200 0 - - Stock Option (Right to Buy)
Taiyin Yang Director 20 Jun 2025 11,333 0 - 0.6 6,460 Common Stock
Taiyin Yang Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 34,000 0 - - Stock Option (Right to Buy)
Taiyin Yang Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 34,000 0 - - Stock Option (Right to Buy)
Taiyin Yang Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 17,000 0 - - Stock Option (Right to Buy)
David M. Tanen Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 19,892 0 - - Stock Option (Right to Buy)
David M. Tanen Director 20 Jun 2025 363,428 0 - 0.6 207,154 Common Stock
David M. Tanen Director 20 Jun 2025 471,230 0 - 0.6 268,601 Common Stock
David M. Tanen Director 20 Jun 2025 26,375 0 - 0.6 15,034 Common Stock
David M. Tanen Director 20 Jun 2025 26,375 0 - 0.6 15,034 Common Stock
David M. Tanen Director 20 Jun 2025 26,375 0 - 0.6 15,034 Common Stock
David M. Tanen Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 85,608 0 - - Stock Option (Right to Buy)
David M. Tanen Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 20,600 0 - - Stock Option (Right to Buy)
David M. Tanen Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 34,000 0 - - Stock Option (Right to Buy)
David M. Tanen Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 34,000 0 - - Stock Option (Right to Buy)
David M. Tanen Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 34,000 0 - - Stock Option (Right to Buy)
Elena H. Ridloff Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 17,000 0 - - Stock Option (Right to Buy)
Elena H. Ridloff Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 15,450 0 - - Stock Option (Right to Buy)
Elena H. Ridloff Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 34,000 0 - - Stock Option (Right to Buy)
Elena H. Ridloff Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 17,000 0 - - Stock Option (Right to Buy)
Elena H. Ridloff Director 20 Jun 2025 25,296 0 - 0.6 14,419 Common Stock
Elena H. Ridloff Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 25,879 0 - - Stock Option (Right to Buy)
Elena H. Ridloff Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 26,871 0 - - Stock Option (Right to Buy)
Roger D. Dansey Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 68,000 0 - - Stock Option (Right to Buy)
Roger D. Dansey Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 5,868 0 - - Stock Option (Right to Buy)
Roger D. Dansey Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 34,000 0 - - Stock Option (Right to Buy)
Roshawn A. Blunt Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 41,200 0 - - Stock Option (Right to Buy)
Roshawn A. Blunt Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 34,000 0 - - Stock Option (Right to Buy)
Roshawn A. Blunt Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 34,000 0 - - Stock Option (Right to Buy)
Roshawn A. Blunt Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 34,000 0 - - Stock Option (Right to Buy)
Katherine Vega Stultz Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 34,000 0 - - Stock Option (Right to Buy)
Katherine Vega Stultz Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 7,079 0 - - Stock Option (Right to Buy)
Katherine Vega Stultz Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 68,000 0 - - Stock Option (Right to Buy)
Deborah Knobelman President & Interim CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 246,390 0 - - Employee Stock Option (Right to Buy)
Deborah Knobelman President & Interim CEO 20 Jun 2025 139,422 0 - 0.6 79,471 Common Stock
Deborah Knobelman President & Interim CEO Sale of securities on an exchange or to another person at price $ 0.87 per share. 05 Jun 2025 24,838 139,422 - 0.9 21,554 Common Stock
Frisbee Allison Chief Administrative Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Oct 2024 72,900 72,900 - - Employee Stock Option (Right to Buy)
Y. Lin Charles Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Oct 2024 72,900 72,900 - - Employee Stock Option (Right to Buy)
Norbert W. Bischofberger Director, PRESIDENT & CEO 27 Jun 2024 410,848 10,597,468 - 1.2 478,843 Common Stock
Norbert W. Bischofberger Director, PRESIDENT & CEO 27 Jun 2024 204,670 10,802,138 - 1.2 254,957 Common Stock
Arie S. Belldegrun Director 25 Jun 2024 34,000 34,000 - - Stock Option (Right to Buy)
Joshua A. Kazam Director 25 Jun 2024 34,000 34,000 - - Stock Option (Right to Buy)
Taiyin Yang Director 25 Jun 2024 34,000 34,000 - - Stock Option (Right to Buy)
David M. Tanen Director 25 Jun 2024 34,000 34,000 - - Stock Option (Right to Buy)
Elena H. Ridloff Director 25 Jun 2024 11,333 25,296 - 0 Common Stock
Elena H. Ridloff Director 25 Jun 2024 17,000 17,000 - - Stock Option (Right to Buy)
Roger D. Dansey Director 25 Jun 2024 34,000 34,000 - - Stock Option (Right to Buy)
Roshawn A. Blunt Director 25 Jun 2024 34,000 34,000 - - Stock Option (Right to Buy)
Katherine Vega Stultz Director 25 Jun 2024 34,000 34,000 - - Stock Option (Right to Buy)
Norbert W. Bischofberger Director, PRESIDENT & CEO 10 Jun 2024 1,378,901 5,749,395 - 0.9 1,208,469 Common Stock
Norbert W. Bischofberger Director, PRESIDENT & CEO 10 Jun 2024 881,913 7,375,616 - 1.2 1,096,041 Common Stock
Norbert W. Bischofberger Director, PRESIDENT & CEO 10 Jun 2024 744,308 6,493,703 - 1.1 814,571 Common Stock
Deborah Knobelman Chief Financial Officer 03 Jun 2024 164,260 164,260 - 0 Common Stock
Deborah Knobelman Chief Financial Officer 03 Jun 2024 246,390 246,390 - - Employee Stock Option (Right to Buy)
Allison Frisbee SR VP, CORP OPERATIONS & LEGAL Sale of securities on an exchange or to another person at price $ 1.05 per share. 21 Feb 2024 12,105 204,510 - 1.1 12,757 Common Stock
Charles Lin Y. SR VP, RESEARCH & DEVELOPMENT Sale of securities on an exchange or to another person at price $ 1.05 per share. 21 Feb 2024 12,036 234,603 - 1.1 12,685 Common Stock
Elizabeth A. Olek SR VP, CLINICAL SCIENCE Sale of securities on an exchange or to another person at price $ 1.05 per share. 21 Feb 2024 7,368 193,275 - 1.1 7,765 Common Stock
W. Norbert Bischofberger Director, PRESIDENT & CEO 15 Feb 2024 699,800 699,800 - - Employee Stock Option (Right to Buy)
W. Norbert Bischofberger Director, PRESIDENT & CEO 15 Feb 2024 270,339 2,811,004 - 0 Common Stock
Jorge DiMartino Chief Medical Officer & VP Sale of securities on an exchange or to another person at price $ 1.18 per share. 04 Jan 2024 12,009 315,246 - 1.2 14,214 Common Stock
Dinsmore Christopher Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 1.18 per share. 04 Jan 2024 7,366 260,969 - 1.2 8,718 Common Stock
Kosacz Barbara COO & General Counsel Sale of securities on an exchange or to another person at price $ 1.18 per share. 04 Jan 2024 10,676 928,966 - 1.2 12,636 Common Stock
DiMartino Jorge Chief Medical Officer & VP Sale of securities on an exchange or to another person at price $ 1.31 per share. 12 Dec 2023 17,367 327,255 - 1.3 22,664 Common Stock
Dinsmore Christopher Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 1.31 per share. 12 Dec 2023 10,032 268,335 - 1.3 13,092 Common Stock
Yasir B. Al-Wakeel Chief Financial Officer Sale of securities on an exchange or to another person at price $ 1.75 per share. 06 Jul 2023 9,617 346,102 - 1.8 16,852 Common Stock
Jorge DiMartino Chief Medical Officer & VP Sale of securities on an exchange or to another person at price $ 1.75 per share. 06 Jul 2023 10,818 344,622 - 1.8 18,956 Common Stock
Christopher Dinsmore Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 1.75 per share. 06 Jul 2023 6,634 278,367 - 1.8 11,625 Common Stock
Arie S. Belldegrun Director 22 Jun 2023 34,000 34,000 - - Stock Option (Right to Buy)
Joshua A. Kazam Director 22 Jun 2023 34,000 34,000 - - Stock Option (Right to Buy)
Taiyin Yang Director 22 Jun 2023 34,000 34,000 - - Stock Option (Right to Buy)
David M. Tanen Director 22 Jun 2023 34,000 34,000 - - Stock Option (Right to Buy)
Elena H. Ridloff Director 22 Jun 2023 11,333 13,963 - 0 Common Stock
Elena H. Ridloff Director 22 Jun 2023 17,000 17,000 - - Stock Option (Right to Buy)
Roger D. Dansey Director 22 Jun 2023 5,868 5,868 - - Stock Option (Right to Buy)
Roshawn A. Blunt Director 22 Jun 2023 34,000 34,000 - - Stock Option (Right to Buy)
Marianne De Backer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 34,000 34,000 - - Stock Option (Right to Buy)
Katherine Vega Stultz Director 22 Jun 2023 7,079 7,079 - - Stock Option (Right to Buy)
Roger D. Dansey Director 20 Apr 2023 68,000 68,000 - - Director Stock Option (Right to Buy)
Katherine Vega Stultz Director 10 Apr 2023 68,000 68,000 - - Director Stock Option (Right to Buy)
Yasir B. Al-Wakeel Chief Financial Officer Sale of securities on an exchange or to another person at price $ 1.74 per share. 24 Feb 2023 9,026 355,719 - 1.7 15,665 Common Stock
Jorge DiMartino Chief Medical Officer & VP Sale of securities on an exchange or to another person at price $ 1.74 per share. 24 Feb 2023 10,153 355,440 - 1.7 17,621 Common Stock
Christopher Dinsmore Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 1.74 per share. 24 Feb 2023 6,291 285,001 - 1.7 10,918 Common Stock
Norbert W. Bischofberger Director, President & CEO 15 Feb 2023 570,868 570,868 - - Employee Stock Option (Right to Buy)
Yasir B. Al-Wakeel Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2023 208,367 208,367 - - Employee Stock Option (Right to Buy)
Yasir B. Al-Wakeel Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2023 138,911 364,745 - 0 Common Stock
Barbara Kosacz COO & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2023 208,367 208,367 - - Employee Stock Option (Right to Buy)
Barbara Kosacz COO & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2023 138,911 939,642 - 0 Common Stock
Jorge DiMartino Chief Medical Officer & VP Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2023 137,008 365,593 - 0 Common Stock
Jorge DiMartino Chief Medical Officer & VP Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2023 205,513 205,513 - - Employee Stock Option (Right to Buy)
Christopher Dinsmore Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2023 179,824 179,824 - - Employee Stock Option (Right to Buy)
Christopher Dinsmore Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2023 119,882 291,292 - 0 Common Stock
Jorge DiMartino Chief Medical Officer & VP Sale of securities on an exchange or to another person at price $ 1.81 per share. 12 Dec 2022 18,657 219,478 - 1.8 33,680 Common Stock
Christopher Dinsmore Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 1.81 per share. 12 Dec 2022 9,138 162,936 - 1.8 16,496 Common Stock
Yasir B. Al-Wakeel Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jul 2022 40,000 40,000 - - Employee Stock Option (Right to Buy)
Yasir B. Al-Wakeel Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jul 2022 53,600 216,841 - 0 Common Stock
Barbara Kosacz COO & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jul 2022 53,600 791,624 - 0 Common Stock
Jorge DiMartino Chief Medical Officer & VP Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jul 2022 60,300 238,135 - 0 Common Stock
Christopher Dinsmore Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jul 2022 43,550 172,074 - 0 Common Stock
Arie S. Belldegrun Director 22 Jun 2022 34,000 34,000 - - Stock Option (Right to Buy)
Joshua A. Kazam Director 22 Jun 2022 34,000 34,000 - - Stock Option (Right to Buy)
Taiyin Yang Director 22 Jun 2022 11,333 11,333 - 0 Common Stock
Taiyin Yang Director 22 Jun 2022 17,000 17,000 - - Stock Option (Right to Buy)
David M. Tanen Director 22 Jun 2022 34,000 34,000 - - Stock Option (Right to Buy)
Otello Stampacchia Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 34,000 34,000 - - Stock Option (Right to Buy)
Elena H. Ridloff Director 22 Jun 2022 34,000 34,000 - - Stock Option (Right to Buy)
Roshawn A. Blunt Director 22 Jun 2022 34,000 34,000 - - Stock Option (Right to Buy)
Marianne De Backer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 11,333 14,083 - 0 Common Stock
Marianne De Backer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 17,000 17,000 - - Stock Option (Right to Buy)
Norbert W. Bischofberger Director, President & CEO 17 May 2022 90,931 303,411 - 3.8 348,529 Common Stock
Norbert W. Bischofberger Director, President & CEO 17 May 2022 206,198 509,609 - 3.7 768,046 Common Stock
Norbert W. Bischofberger Director, President & CEO 17 May 2022 300,000 809,609 - 3.8 1,134,510 Common Stock
Norbert W. Bischofberger Director, President & CEO 16 Feb 2022 400,000 400,000 - - Employee Stock Option (Right to Buy)
Yasir B. Al-Wakeel Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 80,000 80,000 - - Employee Stock Option (Right to Buy)
Yasir B. Al-Wakeel Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 53,600 163,241 - 0 Common Stock
Barbara Kosacz COO & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 80,000 80,000 - - Employee Stock Option (Right to Buy)
Barbara Kosacz COO & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 53,600 738,024 - 0 Common Stock
Jorge DiMartino Chief Medical Officer & VP Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 90,000 90,000 - - Employee Stock Option (Right to Buy)
Jorge DiMartino Chief Medical Officer & VP Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 60,300 177,835 - 0 Common Stock
Christopher Dinsmore Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 43,550 128,524 - 0 Common Stock
Christopher Dinsmore Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 65,000 65,000 - - Employee Stock Option (Right to Buy)
Jorge DiMartino Chief Medical Officer & VP Sale of securities on an exchange or to another person at price $ 12.36 per share. 13 Dec 2021 16,152 117,785 - 12.4 199,687 Common Stock
Jorge DiMartino Chief Medical Officer & VP Sale of securities on an exchange or to another person at price $ 12.82 per share. 13 Dec 2021 250 117,535 - 12.8 3,206 Common Stock
Christopher Dinsmore Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 12.82 per share. 13 Dec 2021 174 84,974 - 12.8 2,231 Common Stock
Christopher Dinsmore Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 12.36 per share. 13 Dec 2021 11,212 85,148 - 12.4 138,614 Common Stock
Norbert W. Bischofberger Director, President & CEO 06 Dec 2021 14,356 212,480 - 12.1 173,492 Common Stock
Marianne De Backer Director Purchase of securities on an exchange or from another person at price $ 11.57 per share. 01 Dec 2021 1,150 2,750 - 11.6 13,306 Common Stock
Roshawn A. Blunt Director 11 Nov 2021 41,200 41,200 - - Director Stock Option (Right to Buy)
Christopher Dinsmore Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 20.81 per share. 04 Oct 2021 9,189 96,360 - 20.8 191,195 Common Stock
Christopher Dinsmore Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Oct 2021 9,189 315,308 - - Employee Stock Option (Right to Buy)
Christopher Dinsmore Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.27 per share. 04 Oct 2021 9,189 105,549 - 3.3 30,048 Common Stock
Christopher Dinsmore Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 21.91 per share. 07 Sep 2021 9,189 96,360 - 21.9 201,302 Common Stock
Christopher Dinsmore Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Sep 2021 9,189 324,497 - - Employee Stock Option (Right to Buy)
Christopher Dinsmore Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.27 per share. 07 Sep 2021 9,189 105,549 - 3.3 30,048 Common Stock
Marianne De Backer Director Purchase of securities on an exchange or from another person at price $ 19.63 per share. 20 Aug 2021 500 1,600 - 19.6 9,815 Common Stock
Marianne De Backer Director Purchase of securities on an exchange or from another person at price $ 19.50 per share. 20 Aug 2021 500 1,100 - 19.5 9,750 Common Stock
Christopher Dinsmore Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 20.59 per share. 02 Aug 2021 9,189 96,360 - 20.6 189,165 Common Stock
Christopher Dinsmore Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2021 9,189 333,686 - - Employee Stock Option (Right to Buy)
Christopher Dinsmore Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.27 per share. 02 Aug 2021 9,189 105,549 - 3.3 30,048 Common Stock
Arie S. Belldegrun Director 22 Jun 2021 20,600 20,600 - - Stock Option (Right to Buy)
Joshua A. Kazam Director 22 Jun 2021 20,600 20,600 - - Stock Option (Right to Buy)
Taiyin Yang Director 22 Jun 2021 5,150 5,150 - - Stock Option (Right to Buy)
David M. Tanen Director 22 Jun 2021 20,600 20,600 - - Stock Option (Right to Buy)
Otello Stampacchia Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2021 20,600 20,600 - - Stock Option (Right to Buy)
Elena Ridloff Director 22 Jun 2021 15,450 15,450 - - Stock Option (Right to Buy)
Marianne De Backer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2021 8,583 8,583 - - Stock Option (Right to Buy)
Marianne De Backer Director Purchase of securities on an exchange or from another person at price $ 25.01 per share. 28 May 2021 600 600 - 25.0 15,006 Common Stock
Jakob Loven Director Sale of securities on an exchange or to another person at price $ 20.84 per share. 16 Apr 2021 25,292 1,344,962 - 20.8 527,085 Common Stock
Jakob Loven Director Sale of securities on an exchange or to another person at price $ 21.56 per share. 16 Apr 2021 7,870 1,337,092 - 21.6 169,677 Common Stock
Jakob Loven Director Sale of securities on an exchange or to another person at price $ 20.63 per share. 16 Apr 2021 19 1,301,537 - 20.6 392 Common Stock
Jakob Loven Director Sale of securities on an exchange or to another person at price $ 20.10 per share. 16 Apr 2021 21,532 1,301,556 - 20.1 432,793 Common Stock
Jakob Loven Director Sale of securities on an exchange or to another person at price $ 21.38 per share. 16 Apr 2021 4,157 1,323,088 - 21.4 88,877 Common Stock
Jakob Loven Director Sale of securities on an exchange or to another person at price $ 20.25 per share. 16 Apr 2021 9,847 1,327,245 - 20.3 199,402 Common Stock
Jakob Loven Director Sale of securities on an exchange or to another person at price $ 21.78 per share. 13 Apr 2021 24,818 1,370,254 - 21.8 540,536 Common Stock
Jakob Loven Director Sale of securities on an exchange or to another person at price $ 23.10 per share. 13 Apr 2021 18,938 1,395,072 - 23.1 437,468 Common Stock
Jakob Loven Director Sale of securities on an exchange or to another person at price $ 22.38 per share. 13 Apr 2021 13,698 1,414,010 - 22.4 306,561 Common Stock
Jakob Loven Director Sale of securities on an exchange or to another person at price $ 25.18 per share. 13 Apr 2021 1,285 1,427,708 - 25.2 32,356 Common Stock
Jakob Loven Director Sale of securities on an exchange or to another person at price $ 24.40 per share. 13 Apr 2021 5,738 1,428,993 - 24.4 140,007 Common Stock
Jakob Loven Director Sale of securities on an exchange or to another person at price $ 23.35 per share. 13 Apr 2021 9,997 1,434,731 - 23.4 233,430 Common Stock
Jakob Loven Director Sale of securities on an exchange or to another person at price $ 26.27 per share. 08 Apr 2021 15,728 1,444,828 - 26.3 413,175 Common Stock
Jakob Loven Director Sale of securities on an exchange or to another person at price $ 27.21 per share. 08 Apr 2021 100 1,444,728 - 27.2 2,721 Common Stock
Jakob Loven Director Sale of securities on an exchange or to another person at price $ 27.91 per share. 08 Apr 2021 24,816 1,482,216 - 27.9 692,615 Common Stock
Jakob Loven Director Sale of securities on an exchange or to another person at price $ 27.09 per share. 08 Apr 2021 38,312 1,507,032 - 27.1 1,037,872 Common Stock
Jakob Loven Director Sale of securities on an exchange or to another person at price $ 27.20 per share. 08 Apr 2021 21,660 1,460,556 - 27.2 589,152 Common Stock
Taiyin Yang Director 25 Mar 2021 41,200 41,200 - - Director Stock Option (Right to Buy)
Marianne De Backer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2021 41,200 41,200 - - Stock Option (right to buy)
Norbert W. Bischofberger Director, President & CEO 10 Dec 2020 198,124 198,124 - 0 Common Stock
Norbert W. Bischofberger Director, President & CEO 10 Dec 2020 297,186 297,186 - - Employee Stock Option (Right to Buy)
Yasir B. Al-Wakeel Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2020 108,633 108,633 - - Employee Stock Option (Right to Buy)
Yasir B. Al-Wakeel Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2020 72,422 109,641 - 0 Common Stock
Barbara Kosacz COO & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2020 104,736 104,736 - - Employee Stock Option (Right to Buy)
Barbara Kosacz COO & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2020 69,824 684,424 - 0 Common Stock
Jorge DiMartino Chief Medical Officer & VP Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2020 133,937 133,937 - 0 Common Stock
Jorge DiMartino Chief Medical Officer & VP Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2020 200,906 200,906 - - Employee Stock Option (Right to Buy)
Christopher Dinsmore Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2020 136,665 136,665 - - Employee Stock Option (Right to Buy)
Christopher Dinsmore Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2020 91,110 96,360 - 0 Common Stock
Arie S. Belldegrun Director 14 Oct 2020 228,315 0 - - Series A Preferred Stock
Arie S. Belldegrun Director 14 Oct 2020 1,304,563 0 - - Series A Preferred Stock
Arie S. Belldegrun Director 14 Oct 2020 650,000 0 - - Series Seed Preferred Stock
Arie S. Belldegrun Director 14 Oct 2020 173,333 0 - - Series Seed Preferred Stock
Arie S. Belldegrun Director 14 Oct 2020 253,251 2,315,314 - 16.2 4,090,004 Common Stock
Arie S. Belldegrun Director 14 Oct 2020 1,376,313 2,062,063 - - Common Stock
Arie S. Belldegrun Director 14 Oct 2020 685,750 685,750 - - Common Stock
Arie S. Belldegrun Director 14 Oct 2020 240,872 679,575 - - Common Stock
Arie S. Belldegrun Director 14 Oct 2020 182,866 438,703 - - Common Stock
John C. Martin Director Purchase of securities on an exchange or from another person at price $ 19.00 per share. 14 Oct 2020 75,800 1,952,364 - 19 1,440,200 Common Stock
John C. Martin Director 14 Oct 2020 205,260 1,876,564 - 16.2 3,314,949 Common Stock
John C. Martin Director 14 Oct 2020 756,971 1,671,304 - - Common Stock
John C. Martin Director 14 Oct 2020 914,333 914,333 - - Common Stock
John C. Martin Director 14 Oct 2020 717,509 0 - - Series A Preferred Stock
John C. Martin Director 14 Oct 2020 866,667 0 - - Series Seed Preferred Stock
Joshua A. Kazam Director 14 Oct 2020 23,556 25,666 - - Common Stock
Joshua A. Kazam Director 14 Oct 2020 65,228 0 - - Series A Preferred Stock
Joshua A. Kazam Director 14 Oct 2020 22,328 0 - - Series Seed Preferred Stock
Joshua A. Kazam Director 14 Oct 2020 68,815 94,481 - - Common Stock
Norbert W. Bischofberger Director, President & CEO 14 Oct 2020 1,651,576 4,089,238 - - Common Stock
Norbert W. Bischofberger Director, President & CEO 14 Oct 2020 185,758 4,274,996 - 16.2 2,999,992 Common Stock
Norbert W. Bischofberger Director, President & CEO 14 Oct 2020 95,500 4,370,496 - 19 1,814,500 Common Stock
Norbert W. Bischofberger Director, President & CEO 14 Oct 2020 263,750 263,750 - - Common Stock
Norbert W. Bischofberger Director, President & CEO 14 Oct 2020 263,750 263,750 - - Common Stock
Norbert W. Bischofberger Director, President & CEO 14 Oct 2020 250,000 0 - - Series Seed Preferred
Norbert W. Bischofberger Director, President & CEO 14 Oct 2020 250,000 0 - - Series Seed Preferred Stock
Norbert W. Bischofberger Director, President & CEO 14 Oct 2020 250,000 0 - - Series Seed Preferred Stock
Norbert W. Bischofberger Director, President & CEO 14 Oct 2020 250,000 0 - - Series Seed Preferred Stock
Norbert W. Bischofberger Director, President & CEO 14 Oct 2020 1,565,475 0 - - Series A Preferred Stock
Norbert W. Bischofberger Director, President & CEO 14 Oct 2020 300,001 0 - - Series Seed Preferred Stock
Norbert W. Bischofberger Director, President & CEO 14 Oct 2020 263,750 263,750 - - Common Stock
Norbert W. Bischofberger Director, President & CEO 14 Oct 2020 263,750 263,750 - - Common Stock
Norbert W. Bischofberger Director, President & CEO 14 Oct 2020 316,501 2,437,662 - - Common Stock
David M. Tanen Director 14 Oct 2020 231,553 363,428 - - Common Stock
David M. Tanen Director 14 Oct 2020 233,405 365,280 - - Common Stock
David M. Tanen Director 14 Oct 2020 68,831 434,111 - - Common Stock
David M. Tanen Director 14 Oct 2020 37,119 471,230 - 16.2 599,472 Common Stock
David M. Tanen Director 14 Oct 2020 219,482 0 - - Series Seed Preferred Stock
David M. Tanen Director 14 Oct 2020 221,237 0 - - Series Seed Preferred Stock
David M. Tanen Director 14 Oct 2020 65,243 0 - - Series A Preferred Stock
Otello Stampacchia Director, Ten Percent Owner 14 Oct 2020 1,304,563 0 - - Series A Preferred Stock
Otello Stampacchia Director, Ten Percent Owner 14 Oct 2020 1,606,220 1,625,671 - - Common Stock
Otello Stampacchia Director, Ten Percent Owner 14 Oct 2020 1,376,313 3,001,984 - - Common Stock
Otello Stampacchia Director, Ten Percent Owner 14 Oct 2020 366,299 3,368,283 - 16.2 5,915,729 Common Stock
Otello Stampacchia Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 19.00 per share. 14 Oct 2020 450,000 3,818,283 - 19 8,550,000 Common Stock
Otello Stampacchia Director, Ten Percent Owner 14 Oct 2020 1,522,484 0 - - Series Seed Preferred Stock
Elena Ridloff Director 14 Oct 2020 2,630 2,630 - 19 49,970 Common Stock
Yasir B. Al-Wakeel Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 19.00 per share. 14 Oct 2020 5,250 37,219 - 19 99,750 Common Stock
Jakob Loven Director 14 Oct 2020 1,376,313 1,376,313 - - Common Stock
Jakob Loven Director 14 Oct 2020 1,304,563 0 - - Series A Preferred Stock
Jakob Loven Director 14 Oct 2020 169,031 1,545,344 - 16.2 2,729,851 Common Stock
Barbara Kosacz COO & General Counsel Purchase of securities on an exchange or from another person at price $ 19.00 per share. 14 Oct 2020 5,250 614,600 - 19 99,750 Common Stock
Christopher Dinsmore Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 19.00 per share. 14 Oct 2020 5,250 5,250 - 19 99,750 Common Stock
Rebecka Belldegrun Director 14 Oct 2020 228,315 0 - - Series A Preferred Stock
Rebecka Belldegrun Director 14 Oct 2020 173,333 0 - - Series Seed Preferred Stock
Rebecka Belldegrun Director 14 Oct 2020 240,872 679,575 - - Common Stock
Rebecka Belldegrun Director 14 Oct 2020 182,866 438,703 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters